Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Nov 09, 2021 1:31am
489 Views
Post# 34103355

Failed $ 1.4 million PP in Sept 2021 = FINANCIAL DIFFICULTY

Failed $ 1.4 million PP in Sept 2021 = FINANCIAL DIFFICULTYMEDV failed to close a $ 1.4 million private placement at 7 cents in September 2021.   This FAILURE speaks volumes of the pending financial results which should confirm FINANCIAL DIFFICULTY and losses.    An investor would not walk away from a 7 cent PP if the pending results were great.   They would have loaded up but instead they walked away. 

Plus results are hampered further because Hampton East closed down, 2 cubes under investigation in California and, Pandemic ending January 4th, 2022 per Pfizer.

There is a reason why MEDV is in panic mode and wants to do a 1 for 15 reverse stock split as they can see the writing on the wall.   Without more funds, it is belly up.   


From the REALIST FROSTY RELIGION


Here is the failed PP

CAN $1.4 Million Equity Private Placement

This investment will be in the form of a non-brokered private placement offering of units (the "Equity Units") at a price of $0.07 per Equity Unit for aggregate gross proceeds of up to $1.4 million (the "Offering"). Each Equity Unit will consist of one common share of the Company and one common share purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder thereof to acquire one common share of the Company at a price of $0.08 for a period of five years following the closing date of the Offering. The Offering is expected to close on or about September 9, 2021 and may close in tranches.

<< Previous
Bullboard Posts
Next >>